Brawn Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Brawn Biotech Ltd. on BSE

Search Inside the pdf :

Brawn Biotech Ltd.

28 May 2025

17.00

-4.87%

Result

Brawn Biotech Ltd - 530207 - AFR For The Qtr/Year Ended 31St March 2025

BSE India

The Board approved AFR for the qtr/year ended 31 March 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	2.35	3.85	3.53	-39.0%	-33.4%
Operating Profit Qtr	-0.55	-0.40	-0.40	-37.5%	-37.5%
Net Profit Qtr	-0.49	-0.43	-0.34	-14.0%	-44.1%
Earning Per Share Adjusted latest Qtr	-1.65	-1.44	-1.14	-14.6%	-44.7%

* Standalone data

Detailed Results

Brawn Biotech Ltd.

28 May 2025

17.00

-4.87%

Company Update

Brawn Biotech Ltd - 530207 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Publication of financial results for the quarter/ year ended 31/03/2025

pdf

Brawn Biotech Ltd.

27 May 2025

17.00

-4.87%

Company Update

Brawn Biotech Ltd - 530207 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Non Applicability of filing of Annual Secretarial Compliance report for FY 31/03/2025.

pdf

Brawn Biotech Ltd.

26 May 2025

17.00

-4.87%

Result

Brawn Biotech Ltd - 530207 - AFR For The Quarter/ Year Ended 31/03/2025

BSE India

The Board approved AFR for Qtr/year ended 31 March 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	2.35	3.85	3.53	-39.0%	-33.4%
Operating Profit Qtr	-0.55	-0.40	-0.40	-37.5%	-37.5%
Net Profit Qtr	-0.49	-0.43	-0.34	-14.0%	-44.1%
Earning Per Share Adjusted latest Qtr	-1.65	-1.44	-1.14	-14.6%	-44.7%

* Standalone data

Detailed Results

Brawn Biotech Ltd.

26 May 2025

17.00

-4.87%

Board Meeting

Brawn Biotech Ltd - 530207 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

The Board approved Audited financial results for the quarter/year ended 31/03/2025

pdf

Brawn Biotech Ltd.

16 May 2025

17.00

-4.87%

Board Meeting

Brawn Biotech Ltd - 530207 - Board Meeting Intimation for To Consider And Approve Inter Alia …

BSE India

Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve To consider and approve inter alia the audited financial results of the Company for the quarter and financial year ended March 31st, 2025

pdf

Brawn Biotech Ltd.

30 Apr 2025

17.00

-4.87%

Corp. Note

Brawn Biotech Ltd - 530207 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBrawn Biotech Ltd 2CIN NO.L74899DL1985PLC022468 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Priyanka Sharma Designation: Company Secretary and Compliance Officer EmailId: solution@brawnbiotech.com Name of the Chief Financial Officer: Pooja Pandey Designation: Chief Financial Officer EmailId: collections@brawnlabs.in Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf